TransMedics: Transportation Supporting Growth [Seeking Alpha]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
TMDX is planning clinical trials to increase the use of its devices in heart and lung transplants, which will be necessary to maintain growth going forward. The Company's valuation is high and there is probably limited room for further multiple expansion. The stock should be supported by continued momentum in the business, though. Caution is warranted as TransMedics' end market is limited, and revenue growth will likely decelerate considerably over the next few years. TransMedics ( NASDAQ: TMDX ) continues to go from strength to strength, with its logistics business performing particularly well in recent quarters. While its core liver market in the US should continue to drive reasonable growth, TransMedics is planning on a Recommended For You Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics (TMDX) Just Reclaimed the 20-Day Moving Average [Yahoo! Finance]Yahoo! Finance
- TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $130.00 to $175.00. They now have a "buy" rating on the stock.MarketBeat
- TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $161.00 price target on the stock.MarketBeat
- TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Stephens. They set an "overweight" rating and a $151.00 price target on the stock.MarketBeat
- The 3.9% return this week takes TransMedics Group's (NASDAQ:TMDX) shareholders three-year gains to 460% [Yahoo! Finance]Yahoo! Finance
TMDX
Earnings
- 4/30/24 - Beat
TMDX
Sec Filings
- 6/7/24 - Form 4
- 6/5/24 - Form 144
- 6/5/24 - Form 4
- TMDX's page on the SEC website